{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T03:21:27Z","timestamp":1775445687535,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":7619,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1034\/j.1600-6143.2002.020206.x","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T03:53:57Z","timestamp":1027655637000},"page":"148-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"title":["Cyclosporine Microemulsion (Neoral\u00ae) Absorption Profiling and Sparse-sample Predictors During the First 3 Months after Renal Transplantation"],"prefix":"10.1016","volume":"2","member":"78","reference":[{"key":"10.1034\/j.1600-6143.2002.020206.x_bib1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00007890-198511000-00001","article-title":"Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters","volume":"40","author":"Kahan","year":"1985","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF01046702","article-title":"Intraindividual variability in the relative systemic availability of cyclosporine after oral dosing","volume":"34","author":"Lindholm","year":"1988","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00007691-199111000-00001","article-title":"Review. factors influencing the pharmacokinetics of cyclosporine in man","volume":"13","author":"Lindholm","year":"1991","journal-title":"Ther Drug Monit"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/clpt.1993.132","article-title":"Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation","volume":"54","author":"Lindholm","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib5","first-page":"837","article-title":"Variations in bioavailability of cyclosporine and relationship to clinical outcome in renal transplant subpopulations","volume":"27","author":"Schroeder","year":"1995","journal-title":"Transplant Proc"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00044011-199713010-00004","article-title":"A pharmacokinetic study of cyclosporin (Sandimmune\u00ae): factors affecting the usefulness of trough levels in predicting drug exposure in renal transplant patients","volume":"13","author":"Primmett","year":"1997","journal-title":"Clin Drug Invest"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib7","series-title":"Immunosuppressive Drugs, Developments in Anti-Rejection Therapy","first-page":"37","article-title":"Pharmacokinetics and monitoring of cyclosporine A","author":"Holt","year":"1994"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib8","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/00007890-199409000-00004","article-title":"Cyclosporine pharmacokinetics and variability from a microemulsion formulation \u2013 a multicenter investigation in kidney transplant patients","volume":"58","author":"Kovarik","year":"1994","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00007890-199559040-00011","article-title":"Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals or high-fat meals","volume":"59","author":"Kahan","year":"1995","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib10","series-title":"Cyclosporine, The Ten-Year Experience.","first-page":"2935","article-title":"The pharmacokinetics of Sandimmun Neoral: a new oral formulation of cyclosporine","author":"Holt","year":"1994"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib11","series-title":"Cyclosporine, The Ten-Year Experience.","first-page":"2932","article-title":"Potential for CsA-Neoral in organ transplantation","author":"Levy","year":"1994"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib12","first-page":"1345","article-title":"A limited sampling strategy for the measurement of cyclosporine AUC","volume":"22","author":"Johnston","year":"1990","journal-title":"Transplant Proc"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib13","series-title":"Cyclosporine, The Ten-Year Experience.","first-page":"2807","article-title":"Abbreviated three-point kinetic profile in the 12-hour area under the curve for pharmacokinetic monitoring of cyclosporine","author":"Serino","year":"1994"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib14","first-page":"1744","article-title":"A randomized, prospective multicentre pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients","volume":"62","year":"1997","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00007691-199806000-00007","article-title":"Cyclosporine monitoring in renal transplant patients: two- or three-point methods that estimate AUC are superior to trough levels in predicting drug exposure","volume":"20","author":"Primmett","year":"1998","journal-title":"Ther Drug Monit"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1399-0012.1998.tb01098.x","article-title":"Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy","volume":"12","author":"Cantarovich","year":"1998","journal-title":"Clin Transplant"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib17","doi-asserted-by":"crossref","DOI":"10.1097\/00007890-199911150-00023","article-title":"The temporal profile of calcineurin inhibition by cyclosporine in vivo","volume":"68","author":"Halloran","year":"1999","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib18","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00007890-200002150-00022","article-title":"Stimulated response of peripheral lymphocytes may distinguish cyclosporine effect in renal transplant recipients receiving a cyclosporine + rapamycin regimen","volume":"69","author":"Sindhi","year":"2000","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib19","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/00007890-200109270-00008","article-title":"Absorption profiling of cyclosporine microemulsion (Neoral) during the first two weeks after renal transplantation.","volume":"72","year":"2001","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00007890-199907150-00011","article-title":"Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation","volume":"68","author":"Mahalati","year":"1999","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib21","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/S0041-1345(99)00089-5","article-title":"Influence of drug formulation on utilization and outcomes: Neoral and monitoring by sparse sample area under the curve","volume":"31","author":"Belitsky","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib22","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(97)09278-7","article-title":"For the CHIB 201 International Study Group. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients","volume":"350","author":"Nashan","year":"1997","journal-title":"Lancet"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib23","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1097\/00007890-200004271-00190","article-title":"Absorption profiling of cyclosporine therapy for de novo kidney transplantation: a prospective, randomized study comparing sparse sampling to trough monitoring","volume":"69","author":"Barama","year":"2000","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib24","first-page":"P0617","article-title":"Absorption profiling of cyclosporine therapy for de novo kidney transplantation: a prospective, randomized study comparing sparse sampling to trough monitoring in kidney transplantation","volume":"327","author":"Perner","year":"2000","journal-title":"In: XVIII Congress of the Transplantation Society, Rome"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib25","first-page":"229","article-title":"Kidney graft loss in children: implications for program development","volume":"159","author":"Crocker","year":"1998","journal-title":"CMAJ"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00007890-199609150-00010","article-title":"Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection","volume":"62","author":"Kahan","year":"1996","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib27","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1399-0012.1996.tb00733.x","article-title":"The importance of early cyclosporine levels in pediatric kidney transplantation","volume":"10","author":"Matas","year":"1996","journal-title":"Clin Transplant"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s004670050303","article-title":"Risk factors for chronic rejection in pediatric renal transplant recipients \u2013 a single-center experience","volume":"11","author":"Birk","year":"1997","journal-title":"Pediatr Nephrol"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1432-2277.1999.tb00607.x","article-title":"Long-term maintenance of therapeutic cyclosporine levels leads to optimal graft survival without evidence of chronic nephrotoxicity","volume":"12","author":"Lipkowitz","year":"1999","journal-title":"Transpl Int"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1432-2277.1998.tb00955.x","article-title":"Impact of early cyclosporin average blood concentration on early kidney transplant failure","volume":"11","author":"Senel","year":"1998","journal-title":"Transpl Int"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib31","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1046\/j.1523-1755.1998.00042.x","article-title":"for the International Sandimmun Neoral Study Group. Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation","volume":"54","author":"Keown","year":"1998","journal-title":"Kidney Int"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0090-9556(24)15271-3","article-title":"Molecular and physical mechanisms of first-pass extraction","volume":"27","author":"Hall","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1034\/j.1600-6143.2002.020206.x_bib33","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1021\/js980082d","article-title":"Role of p-glycoprotein and cytochrome P450, 3A in limiting oral absorption of peptides and peptidomimetics","volume":"87","author":"Wacher","year":"1998","journal-title":"J Pharm Sci"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-6143.2002.020206.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-6143.2002.020206.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522070708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522070708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1034\/j.1600-6143.2002.020206.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:25:52Z","timestamp":1761625552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522070708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["S1600613522070708"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-6143.2002.020206.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclosporine Microemulsion (Neoral\u00ae) Absorption Profiling and Sparse-sample Predictors During the First 3 Months after Renal Transplantation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1034\/j.1600-6143.2002.020206.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}